Siga Technologies News and Activities

Siga Technologies is owned by MacAndrews & Forbes.

MacAndrews & Forbes has 3 subsidiaries including Siga Technologies, Vericast and vTv Therapeutics.

They are in:

• Holding25%
• Biotechnology25%
• Other50%

View the org chart displaying its 20 main executives

Most searched biographies at Siga Technologies

• Nguyen Diem, Chief Executive Officer and Director
• Gary Nabel, Director
• John Keane, Director

Create your alert
to follow the executive moves at Siga Technologies.

MacAndrews & Forbes has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
• NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).
• Rallybio and Avenzo Therapeutics have announced they will merge  (posted on June 1 2026)..

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Siga Technologies

• SIGA Technologies to Host Business Update Call on August 4th, 2022 Following Release of Second Quarter 2022 Financial Results | SIGA
• SIGA Announces Oncology Collaboration with KaliVir Immunotherapeutics | SIGA
• SIGA Announces Approximately $28 Million of International Procurement Orders for Oral TPOXX® (Tecovirimat) | SIGA
• SIGA Technologies Receives Approval from UK for Tecovirimat | SIGA
• SIGA Announces $13 Million of International Procurement Orders for Oral TPOXX® (Tecovirimat) | SIGA
• SIGA to Participate in Alliance Global Partners’ Monkeypox Panel on Thursday, June 23rd 2022 | SIGA
• Press Releases | SIGA
• Press Releases | SIGA
• SIGA Receives Approval from the FDA for Intravenous (IV) Formulation of TPOXX® (tecovirimat) | SIGA
• New Contract Awarded by U.S. Department of Defense for the Procurement of up to Approximately $7.5 Million of Oral TPOXX® | SIGA
• View more press releases Close

Social media about Siga Technologies

• Siga Technologies on Wikipedia, Google News & Yahoo Finance
• Siga Technologies on LinkedIn, X (Twitter) & YouTube